# Ron Handels

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/ron-handels/

## Facts

| Field | Value |
| --- | --- |
| Citations | 3,664 |
| Field | Dementia and Cognitive Impairment Research |
| h-index | 27 |
| i10-index | 57 |
| Last Known Institution | Karolinska Institutet |
| OpenAlex ID | https://openalex.org/A5081841043 |
| ORCID iD | 0000-0002-8663-0630 |
| Works | 133 |

## Researcher papers

- [Duration of preclinical, prodromal, and dementia stages of Alzheimer's disease in relation to age, sex, and <i>APOE</i> genotype](https://scholariq.org/papers/duration-of-preclinical-prodromal-and-dementia-stages-of-alzheimer-s-disease-in/)
- [Cerebrospinal fluid and blood biomarkers for neurodegenerative dementias: An update of the Consensus of the Task Force on Biological Markers in Psychiatry of the World Federation of Societies of Biological Psychiatry](https://scholariq.org/papers/cerebrospinal-fluid-and-blood-biomarkers-for-neurodegenerative-dementias-an/)
- [Prevalence Estimates of Amyloid Abnormality Across the Alzheimer Disease Clinical Spectrum](https://scholariq.org/papers/prevalence-estimates-of-amyloid-abnormality-across-the-alzheimer-disease/)
- [Impact of molecular imaging on the diagnostic process in a memory clinic](https://scholariq.org/papers/impact-of-molecular-imaging-on-the-diagnostic-process-in-a-memory-clinic/)
- [Biomarkers as Predictors for Conversion from Mild Cognitive Impairment to Alzheimer-Type Dementia: Implications for Trial Design](https://scholariq.org/papers/biomarkers-as-predictors-for-conversion-from-mild-cognitive-impairment-to/)
- [Recommendations for cerebrospinal fluid Alzheimer's disease biomarkers in the diagnostic evaluation of mild cognitive impairment](https://scholariq.org/papers/recommendations-for-cerebrospinal-fluid-alzheimer-s-disease-biomarkers-in-the/)
- [Recommendations for CSF AD biomarkers in the diagnostic evaluation of dementia](https://scholariq.org/papers/recommendations-for-csf-ad-biomarkers-in-the-diagnostic-evaluation-of-dementia/)
- [The affordability of lecanemab, an amyloid-targeting therapy for Alzheimer's disease: an EADC-EC viewpoint](https://scholariq.org/papers/the-affordability-of-lecanemab-an-amyloid-targeting-therapy-for-alzheimer-s/)
- [Health-related quality of life in people with predementia Alzheimer’s disease, mild cognitive impairment or dementia measured with preference-based instruments: a systematic literature review](https://scholariq.org/papers/health-related-quality-of-life-in-people-with-predementia-alzheimer-s-disease/)
- [Needs and quality of life of people with middle-stage dementia and their family carers from the European Actifcare study. When informal care alone may not suffice](https://scholariq.org/papers/needs-and-quality-of-life-of-people-with-middle-stage-dementia-and-their-family/)
- [Caregiver Burden and Quality of Life Across Alzheimer’s Disease Severity Stages](https://scholariq.org/papers/caregiver-burden-and-quality-of-life-across-alzheimer-s-disease-severity-stages/)

## Researcher topics

- [Dementia and Cognitive Impairment Research](https://scholariq.org/topics/dementia-and-cognitive-impairment-research/)
- [Health Systems, Economic Evaluations, Quality of Life](https://scholariq.org/topics/health-systems-economic-evaluations-quality-of-life/)
- [Alzheimer's disease research and treatments](https://scholariq.org/topics/alzheimer-s-disease-research-and-treatments/)
- [Geriatric Care and Nursing Homes](https://scholariq.org/topics/geriatric-care-and-nursing-homes/)
- [Intergenerational Family Dynamics and Caregiving](https://scholariq.org/topics/intergenerational-family-dynamics-and-caregiving/)

## Researcher university

- [Karolinska Institutet](https://scholariq.org/institutions/karolinska-institutet/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.